PROGRESSIVE MULTIPLE SCLEROSIS

Size: px
Start display at page:

Download "PROGRESSIVE MULTIPLE SCLEROSIS"

Transcription

1 page 1 / 5

2 page 2 / 5

3 progressive multiple sclerosis pdf Introduction. Multiple Sclerosis (MS) is a chronic inflammatory, demyelinating, and neurodegenerative disorder of the central nervous system (CNS) that affects the white and grey matter of the brain, spinal cord, and optic nerve. Multiple Sclerosis - clevelandclinicmeded.com A MEDLINE search from inception to Nov 9, 2017, with language restrictions, with the search terms ( secondary progressive multiple sclerosis [Title] OR secondary progressive MS [Title] OR SPMS [Title]), identified 320 articles; search results were supplemented by a review of abstracts from recent major neurology conferences. Siponimod versus placebo in secondary progressive multiple Evidence before this study. A MEDLINE search from inception to Nov 9, 2017, with language restrictions, with the search terms ( secondary progressive multiple sclerosis [Title] OR secondary progressive MS [Title] OR SPMS [Title]), identified 320 articles; search results were supplemented by a review of abstracts from recent major neurology conferences. Siponimod versus placebo in secondary progressive multiple New version of Multiple Sclerosis and Related Disorders app now available for ios and Android! Multiple Sclerosis and Related Disorders Home Page Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). Several therapies for it exist, although there is no known cure. The most common initial course of the disease is the relapsingremitting subtype, which is characterized by unpredictable attacks followed by periods of relative remission with no new signs of disease activity. Management of multiple sclerosis - Wikipedia Treatment. There is no cure for multiple sclerosis. Treatment typically focuses on speeding recovery from attacks, slowing the progression of the disease and managing MS symptoms. Multiple sclerosis - Diagnosis and treatment - Mayo Clinic Multiple sclerosis (MS) is a serious health condition that gets worse over time. In this disease, the body s natural guard against illness (the immune system) damages fatty coverings called myelin sheaths around the nerve cells (neurons) in the central nervous system. The disease has different effects in different people, and can make people s bodies, eyesight, speech, and minds work poorly. Multiple sclerosis - Simple English Wikipedia, the free List of Multiple Sclerosis Organizations in different countries around the world List of multiple sclerosis organizations - Wikipedia General Discussion Multiple sclerosis (MS) is a chronic neuroimmunologic (both the nervous system and the immunological system are involved) disorder of the central nervous system involving the brain, spinal cord and optic nerves. Multiple Sclerosis - NORD (National Organization for Rare Types of MS. Four disease courses have been identified in multiple sclerosis: clinically isolated syndrome (CIS), relapsingremitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS). Types of MS : National Multiple Sclerosis Society Medications are used in multiple sclerosis (MS) to modify the disease course, treat relapses also called attacks or exacerbations and manage symptoms.along with the other essential components of comprehensive MS care, these medications help people manage their MS and enhance their comfort and quality of life. Medications : National Multiple Sclerosis Society page 3 / 5

4 Multiple sclerosis signs and symptoms may differ greatly from person to person and over the course of the disease depending on the location of affected nerve fibers. Multiple sclerosis - Symptoms and causes - Mayo Clinic Introduction. Tumefactive multiple sclerosis (MS) is a rare variant of MS. This form of MS can masquerade as neoplasm or infectious etiology. Understanding of the disease is limited to case report but it is associated with high morbidity and mortality. Tumefactive Multiple sclerosis British Journal of Summary. Multiple sclerosis is a condition where the body s immune system attacks the nerves in the brain and spinal cord. Because these nerves provide messages to so many different areas of the body, the symptoms of multiple sclerosis can involve many systems of the body. Vitamin D and multiple sclerosis Multiple sclerosis (MS) is an inflammatory and neurodegenerative demyelinating disease of the CNS, the onset of which usually occurs in young adulthood. Treatment of multiple sclerosis success from bench to Explains the 4 types of MS (RRMS, SPMS, PPMS, PRMS), the importance of early treatment, and the common MS treatments, eg, beta interferon. The 4 Types of MS - Multiple sclerosis Multiple sclerosis is an autoimmune disease with a genetic origin. The condition is characterized by an attack on the brain mediated by the immune system, leading to diverse symptoms caused by... Multiple sclerosis enters a grey area - nature.com INTRODUCTION Multiple sclerosis (MS) is an immune-mediated inflammatory demyelinating disease of the central nervous system that is a leading cause of disability in young adults.. The treatment of relapsing forms of MS is reviewed here, primarily focused on disease-modifying therapies. The treatment of progressive forms of MS is reviewed elsewhere. UpToDate The concept of induction followed by a long-term maintenance treatment has attracted much attention for the treatment of multiple sclerosis over the 30 past years. Induction or escalation therapy for patients with multiple Looking for a way to help advance knowledge about Multiple Sclerosis Caregiving? I know a way. I have just completed an online survey which is sponsored by the National Alliance for Caregiving and the National Multiple Sclerosis Society. Multiple Sclerosis Caregiving - Doing Your Best Does Make The purpose of this study was to establish the efficacy and safety of two different doses of alemtuzumab (Lemtrada ) as a treatment for relapsing-remitting multiple sclerosis (MS), in comparison with subcutaneous interferon beta-1a (Rebif ). Comparison of Alemtuzumab and Rebif Efficacy in Multiple A new study has shown that drinking hot chocolate daily could help to reduce fatigue and tiredness among people suffering from MS (multiple sclerosis). The results of this new study were published... Cocoa can benefit patients with multiple sclerosis Measuring burden in caregivers of people with multiple sclerosis: psychometric properties of the CSI questionnaire Jose M García-Domínguez,1 María L Martínez-Ginés,1 Olga Carmona,2 Ana B Caminero,3 Daniel Prefasi,4 Jorge Maurino,4 Javier Ballesteros5 On behalf of the W-IMPACT Clinical Investigators 1Department of Neurology, Hospital Universitario Gregorio Marañón, Madrid... Measuring burden in caregivers of people with multiple Treatment of acute exacerbations of multiple sclerosis (MS) when the acute relapse is characterized by functionally disabling page 4 / 5

5 Powered by TCPDF ( symptoms with documented evidence of neurological impairment (persons who have previously responded in a relapse phase are more likely to do so in the future); or Multiple Sclerosis - Medical Clinical Policy Bulletins Aetna Assessment report EMA/790835/2017 Page 6/180 OD optical density PALM Post-Approval Lifecycle Management PAR Proven Acceptable Range Assessment report - ema.europa.eu Multipel sklerose eller Multipel sclerose (forkortet MS, kaldes også encephalomyelitis disseminata, dissemineret sklerose, dissemineret sclerose, sclerosis disseminata eller blot sklerose/sclerose) er en kronisk, uhelbredelig neurologisk sygdom, som rammer centralnervesystemet, det vil sige hjernen og rygmarven.mere præcist er det en sygdom i hvilken myelinskeder omkring hjernens og... page 5 / 5

DOWNLOAD OR READ : MULTIPLE SCLEROSIS THE HISTORY OF A DISEASE PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : MULTIPLE SCLEROSIS THE HISTORY OF A DISEASE PDF EBOOK EPUB MOBI DOWNLOAD OR READ : MULTIPLE SCLEROSIS THE HISTORY OF A DISEASE PDF EBOOK EPUB MOBI Page 1 Page 2 multiple sclerosis the history of a disease multiple sclerosis the history pdf multiple sclerosis the history

More information

DOWNLOAD OR READ : MULTIPLE SCLEROSIS HOW I WON THE BATTLE PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : MULTIPLE SCLEROSIS HOW I WON THE BATTLE PDF EBOOK EPUB MOBI DOWNLOAD OR READ : MULTIPLE SCLEROSIS HOW I WON THE BATTLE PDF EBOOK EPUB MOBI Page 1 Page 2 multiple sclerosis how i won the battle multiple sclerosis how i pdf multiple sclerosis how i won the battle

More information

DOWNLOAD OR READ : MULTIPLE SCLEROSIS PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : MULTIPLE SCLEROSIS PDF EBOOK EPUB MOBI DOWNLOAD OR READ : MULTIPLE SCLEROSIS PDF EBOOK EPUB MOBI Page 1 Page 2 multiple sclerosis multiple sclerosis pdf multiple sclerosis Treatment. There is no cure for multiple sclerosis. Treatment typically

More information

Multiple Sclerosis Diagnosis And Therapy

Multiple Sclerosis Diagnosis And Therapy Multiple Sclerosis Diagnosis And Therapy 1 / 6 2 / 6 3 / 6 Multiple Sclerosis Diagnosis And Therapy Treatment. There is no cure for multiple sclerosis. Treatment typically focuses on speeding recovery

More information

Multiple Sclerosis. Biology 12 Nervous System Project

Multiple Sclerosis. Biology 12 Nervous System Project Multiple Sclerosis Biology 12 Nervous System Project Overview Multiple Sclerosis (MS) is a progressive and unpredictable disorder that affects the central nervous system. Figure 1: The central nervous

More information

Progress in MS: Current and Emerging Therapies. Presented by: Dr. Kathryn Giles, MD MSc FRCPC Cambridge, Ontario, Canada

Progress in MS: Current and Emerging Therapies. Presented by: Dr. Kathryn Giles, MD MSc FRCPC Cambridge, Ontario, Canada Progress in MS: Current and Emerging Therapies Presented by: Dr. Kathryn Giles, MD MSc FRCPC Cambridge, Ontario, Canada Today s Discussion Natural History and Classification of MS Treating MS Management

More information

MULTIPLE SCLEROSIS - REVIEW AND UPDATE

MULTIPLE SCLEROSIS - REVIEW AND UPDATE MULTIPLE SCLEROSIS - REVIEW AND UPDATE Luka Vlahovic, MD Neuroimmunology/Multiple Sclerosis Creighton University Medical Center MS is primary demyelinating disease of the central nervous system. MS is

More information

MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease

MEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease MEDIA BACKGROUNDER Multiple Sclerosis: A serious and unpredictable neurological disease Multiple sclerosis (MS) is a complex chronic inflammatory disease of the central nervous system (CNS) that still

More information

Investor Update. Downloads. Services PDF. Basel, 17 July 2017

Investor Update. Downloads. Services PDF. Basel, 17 July 2017 Investor Update Basel, 17 July 2017 Roche s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia Second approval after the US for OCREVUS as the first and

More information

Media Release. Basel, 10 November 2017

Media Release. Basel, 10 November 2017 Media Release Basel, 10 November 2017 Roche s OCREVUS (ocrelizumab) gains positive CHMP opinion for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis If approved, OCREVUS

More information

What is Multiple Sclerosis? Gener al information

What is Multiple Sclerosis? Gener al information What is Multiple Sclerosis? Gener al information Kim, diagnosed in 1986 What is MS? Multiple sclerosis (or MS) is a chronic, often disabling disease that attacks the central nervous system (brain and spinal

More information

Roche s OCREVUS (ocrelizumab) approved in Switzerland for primary progressive and relapsing forms of multiple sclerosis

Roche s OCREVUS (ocrelizumab) approved in Switzerland for primary progressive and relapsing forms of multiple sclerosis Media Release Basel, 28 September 2017 Roche s OCREVUS (ocrelizumab) approved in Switzerland for primary progressive and relapsing forms of multiple sclerosis OCREVUS is the first and only approved treatment

More information

Le Hua, MD. Disclosures Teaching and Speaking: Teva Neurosciences, Genzyme, Novartis Advisory Board: Genzyme, EMD Serono

Le Hua, MD. Disclosures Teaching and Speaking: Teva Neurosciences, Genzyme, Novartis Advisory Board: Genzyme, EMD Serono Le Hua, MD Le Hua, MD, is a staff neurologist at Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, NV. She is involved in clinical trials assessing new therapies for the treatment of MS and

More information

Positive Phase III results for Roche s investigational medicine OCREVUS (ocrelizumab) published in New England Journal of Medicine

Positive Phase III results for Roche s investigational medicine OCREVUS (ocrelizumab) published in New England Journal of Medicine Media Release Basel 21 December 2016 Positive Phase III results for Roche s investigational medicine OCREVUS (ocrelizumab) published in New England Journal of Medicine OCREVUS is the first and only investigational

More information

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012

Medication Policy Manual. Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 16, 2016 Next Review Date: December 2017 Effective Date: January

More information

Multiple Sclerosis. Brain Spinal Cord. Peripheral Nerves

Multiple Sclerosis. Brain Spinal Cord. Peripheral Nerves Multiple Sclerosis Introduction Multiple sclerosis, or MS, is a disease of the brain and spinal cord. It affects about 400,000 Americans at any one time. Most patients with multiple sclerosis are able

More information

Medication Policy Manual. Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013

Medication Policy Manual. Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013 Medication Policy Manual Policy No: dru299 Topic: Tecfidera, dimethyl fumarate Date of Origin: May 16, 2013 Committee Approval Date: December 16, 2016 Next Review Date: December 2017 Effective Date: January

More information

Biologics and Beyond: Treatment of Multiple Sclerosis. Rita Jebrin, PharmD, BCPS

Biologics and Beyond: Treatment of Multiple Sclerosis. Rita Jebrin, PharmD, BCPS Biologics and Beyond: Treatment of Multiple Sclerosis Rita Jebrin, PharmD, BCPS Disclosure Information Biologics and Beyond: Treatment of Multiple Sclerosis Rita Jebrin, PharmD, BCPS I have no financial

More information

Relapsing Remitting Multiple Sclerosis: How To Cope With Multiple Sclerosis By La Tasha Shelton READ ONLINE

Relapsing Remitting Multiple Sclerosis: How To Cope With Multiple Sclerosis By La Tasha Shelton READ ONLINE Relapsing Remitting Multiple Sclerosis: How To Cope With Multiple Sclerosis By La Tasha Shelton READ ONLINE If looking for a book by La Tasha Shelton Relapsing Remitting Multiple Sclerosis: How to Cope

More information

Committee Approval Date: December 12, 2014 Next Review Date: December 2015

Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Medication Policy Manual Policy No: dru283 Topic: Aubagio, teriflunomide Date of Origin: November 9, 2012 Committee Approval Date: December 12, 2014 Next Review Date: December 2015 Effective Date: January

More information

Multiple Sclerosis , The Patient Education Institute, Inc. nr Last reviewed: 04/17/2017 1

Multiple Sclerosis , The Patient Education Institute, Inc.  nr Last reviewed: 04/17/2017 1 Multiple Sclerosis Introduction Multiple sclerosis, or MS, is a disease of the brain and spinal cord. Most patients with multiple sclerosis are able to lead a very functional life. However, MS causes a

More information

GILENYA (fingolimod) oral capsule

GILENYA (fingolimod) oral capsule GILENYA (fingolimod) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

Multiple Sclerosis. What is multiple sclerosis? What is the cause? What are the symptoms?

Multiple Sclerosis. What is multiple sclerosis? What is the cause? What are the symptoms? What is multiple sclerosis? Multiple Sclerosis Multiple sclerosis (MS) is a disease of the central nervous system (the brain and spinal cord). Many people with multiple sclerosis are only mildly affected

More information

Get on with life, we ll see you. in 6 months. Living your life your way with MS

Get on with life, we ll see you. in 6 months. Living your life your way with MS Get on with life, we ll see you in 6 months. Living your life your way with MS If you re one of the 4000 New Zealanders affected by MS, ask your doctor or nurse if OCREVUS is right for you. Contents What

More information

DOWNLOAD OR READ : THE PROGRESSIVE VIRUS PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : THE PROGRESSIVE VIRUS PDF EBOOK EPUB MOBI DOWNLOAD OR READ : THE PROGRESSIVE VIRUS PDF EBOOK EPUB MOBI Page 1 Page 2 the progressive virus the progressive virus pdf the progressive virus Progressive Multifocal Leukoencephalopathy (PML) is an opportunistic

More information

Epidemiology. Geographical distribution: Average onset age: years

Epidemiology. Geographical distribution: Average onset age: years Multiple sclerosis chronical disease, characterized by multiple areas of inflamation and demielination in the CNS One of the major causes of disability in the young adult Variable clinical picture and

More information

MULTIPLE SCLEROSIS PROFILE

MULTIPLE SCLEROSIS PROFILE MULTIPLE SCLEROSIS PROFILE What is Multiple Sclerosis? Multiple sclerosis (MS) is a chronic, inflammatory disease of unknown etiology that involves an immune-mediated attack on the central nervous system

More information

TECFIDERA (dimethyl fumarate) oral capsule

TECFIDERA (dimethyl fumarate) oral capsule TECFIDERA (dimethyl fumarate) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Relapsing Remitting Multiple Sclerosis: How To Cope With Multiple Sclerosis By La Tasha Shelton READ ONLINE

Relapsing Remitting Multiple Sclerosis: How To Cope With Multiple Sclerosis By La Tasha Shelton READ ONLINE Relapsing Remitting Multiple Sclerosis: How To Cope With Multiple Sclerosis By La Tasha Shelton READ ONLINE If looking for a ebook by La Tasha Shelton Relapsing Remitting Multiple Sclerosis: How to Cope

More information

Potential Rebalancing of the Immune System by Anti-CD52 Therapy

Potential Rebalancing of the Immune System by Anti-CD52 Therapy Potential Rebalancing of the Immune System by Anti-CD52 Therapy Johanne Kaplan, PhD VP Neuroimmunology Research Genzyme March 26, 2013 RESTRICTED USE SEE TRAINING MEMO 2011 DO Genzyme NOT 1COPY Corporation

More information

MULTIPLE SCLEROSIS INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

MULTIPLE SCLEROSIS INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to: MULTIPLE SCLEROSIS INTRODUCTION Multiple sclerosis (MS) is a chronic disease of the nervous system. Multiple sclerosis causes inflammation and damage to the protective coatings in the brain and the nerves.

More information

Choices. Types of MS. Read me

Choices. Types of MS. Read me Choices Types of MS Read me Types of MS Although multiple sclerosis affects individuals very differently, there are four broad groups into which MS is categorised. Clinically Isolated Syndrome Clinically

More information

Media Release. Basel 12 January 2018

Media Release. Basel 12 January 2018 Media Release Basel 12 January 2018 Roche s OCREVUS (ocrelizumab) approved in the European Union for relapsing forms of multiple sclerosis and primary progressive multiple sclerosis First and only approved

More information

The Complete Guide To Multiple Sclerosis Symptoms: How To Manage Multiple Sclerosis, MS Pain And Control MS Disease Naturally By Benjamin Weber

The Complete Guide To Multiple Sclerosis Symptoms: How To Manage Multiple Sclerosis, MS Pain And Control MS Disease Naturally By Benjamin Weber The Complete Guide To Multiple Sclerosis Symptoms: How To Manage Multiple Sclerosis, MS Pain And Control MS Disease Naturally By Benjamin Weber No single test gives a definitive diagnosis for MS, and variable

More information

Hot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018

Hot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018 Hot Topics Multiple Sclerosis Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018 Disclosures Natalie Parks has received compensation from Biogen, EMD Serono, Roche, and Sanofi

More information

Prof. Dimitrios Karussis Director of the Hadassah Center for MS

Prof. Dimitrios Karussis Director of the Hadassah Center for MS The Center for Multiple Sclerosis (MS) provides the patient a multidisciplinary approach for the management of the various problems related to MS and with the best available of experimental treatments

More information

GILENYA (fingolimod) oral capsule

GILENYA (fingolimod) oral capsule GILENYA (fingolimod) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage

More information

Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow

Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow Reading: Robbins & Cotran, 9 th edition, pp 1283-1286 Robbins Basic Pathology, 9 th edition, 832-835 Overview: Grossly, myelin is

More information

Thinking and Memory in MS

Thinking and Memory in MS Thinking and Memory in MS Ben Harris (MPsych, PhD) Clinical Neuropsychologist Overview Basic structure of the brain and how signals are communicated between different areas Changes to the brain associated

More information

Mitzi Joi Williams, MD Neurologist MS Center of Atlanta Atlanta, GA

Mitzi Joi Williams, MD Neurologist MS Center of Atlanta Atlanta, GA Mitzi Joi Williams, MD Neurologist MS Center of Atlanta Atlanta, GA Disclosures Consultant and Speaker Bureau member for Biogen-Idec, Pfizer, TEVA Neuroscience, Bayer, EMD Serrono, Questcor, Novartis,

More information

Multiple Sclerosis. By: Selena Fucci April 22, 2016

Multiple Sclerosis. By: Selena Fucci April 22, 2016 Multiple Sclerosis By: Selena Fucci April 22, 2016 Abstract: Multiple Sclerosis, MS, is a chronic neurological disorder in the brain and spinal cord involving inflammation and demyelination of the central

More information

AUBMC Multiple Sclerosis Center

AUBMC Multiple Sclerosis Center American University of Beirut Medical Center PO Box: 11-0236 Riad El Solh, Beirut 1107 2020 Beirut - Lebanon www.aubmc.org AUBMC Multiple Sclerosis Center 1 AUBMC Multiple Sclerosis Center The vision of

More information

Current Enrolling Clinical Trials

Current Enrolling Clinical Trials ASSESS RRMS patients with active disease who are still able to walk. Mariko Kita MD Description of Study/Trial: A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety

More information

Chronic Inflammatory Demyelinating Polyneuropathy (C.I.D.P.)

Chronic Inflammatory Demyelinating Polyneuropathy (C.I.D.P.) University Teaching Trust Chronic Inflammatory Demyelinating Polyneuropathy (C.I.D.P.) Neurology 0161 206 2323 All Rights Reserved 2016. Document for issue as handout. Information about Chronic Inflammatory

More information

DOWNLOAD OR READ : NERVOUS AND MENTAL DISEASE MONOGRAPH SERIES NO 4 SELECTED PAPERS ON HYSTERIA AND OTHER PSYCHONEUROSES PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : NERVOUS AND MENTAL DISEASE MONOGRAPH SERIES NO 4 SELECTED PAPERS ON HYSTERIA AND OTHER PSYCHONEUROSES PDF EBOOK EPUB MOBI DOWNLOAD OR READ : NERVOUS AND MENTAL DISEASE MONOGRAPH SERIES NO 4 SELECTED PAPERS ON HYSTERIA AND OTHER PSYCHONEUROSES PDF EBOOK EPUB MOBI Page 1 Page 2 nervous and mental disease monograph series no

More information

Multiple Sclerosis. What types of MS are there? 4 There are 4 types of MS.

Multiple Sclerosis. What types of MS are there? 4 There are 4 types of MS. Multiple Sclerosis What is Multiple Sclerosis? 1,2 Multiple Sclerosis (MS) is a nervous system disease that affects the brain and spinal cord. The cause of MS is unknown. But, many investigators believe

More information

Relapses Matter A GUIDE TO REPORTING MULTIPLE SCLEROSIS SYMPTOMS

Relapses Matter A GUIDE TO REPORTING MULTIPLE SCLEROSIS SYMPTOMS Relapses Matter A GUIDE TO REPORTING MULTIPLE SCLEROSIS SYMPTOMS Scientific Review by: COLLEEN HARRIS, MN, NP, MSCN Nurse Practitioner/Coordinator University of Calgary MS Program Calgary, Alberta The

More information

Welcome to today s webinar: Learn about MS

Welcome to today s webinar: Learn about MS Welcome to today s webinar: Learn about MS Your Presenter is Dr Todd Hardy Your Facilitator is Belinda Saunders Housekeeping Thanks for joining us for this webinar welcome! You will be able to: hear the

More information

A cost utility model of interferon beta-1b in the treatment of relapsing-remitting multiple sclerosis Phillips C J, Gilmour L, Gale R, Palmer M

A cost utility model of interferon beta-1b in the treatment of relapsing-remitting multiple sclerosis Phillips C J, Gilmour L, Gale R, Palmer M A cost utility model of interferon beta-1b in the treatment of relapsing-remitting multiple sclerosis Phillips C J, Gilmour L, Gale R, Palmer M Record Status This is a critical abstract of an economic

More information

AUBAGIO (teriflunomide) oral tablet

AUBAGIO (teriflunomide) oral tablet AUBAGIO (teriflunomide) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Authors' objectives To evaluate the efficacy of intravenous immunoglobulin (IVIG) for neurologic conditions.

Authors' objectives To evaluate the efficacy of intravenous immunoglobulin (IVIG) for neurologic conditions. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review Fergusson D, Hutton B, Sharma M, Tinmouth A, Wilson K, Cameron D W, Hebert P C CRD summary This review assessed

More information

Carolyn Taylor, M.D. Swedish Neuroscience Center

Carolyn Taylor, M.D. Swedish Neuroscience Center Carolyn Taylor, M.D. Swedish Neuroscience Center When should disease modifying therapy be discontinued in MS? Should we be using aggressive treatments earlier in the MS disease course and reserving the

More information

Welcome to todays Webinar

Welcome to todays Webinar Welcome to todays Webinar Your Presenter is: Lyndal Emery Your Facilitator is: Andrea Salmon Acknowledgement We acknowledge and pay respect to the traditional custodians past and present on whose lands

More information

DOC // HOW STROKES AFFECT THE BRAIN EBOOK

DOC // HOW STROKES AFFECT THE BRAIN EBOOK 17 February, 2018 DOC // HOW STROKES AFFECT THE BRAIN EBOOK Document Filetype: PDF 503.33 KB 0 DOC // HOW STROKES AFFECT THE BRAIN EBOOK They occur when the blood supply to the brain becomes. This phenomenon

More information

Treatment Expectations and Priorities of People with MS

Treatment Expectations and Priorities of People with MS Treatment Expectations and Priorities of People with MS Prepared by Spoonful of Sugar 97 Tottenham Court Road London W1T 4TP Date: October 2017 Spoonful of Sugar 2017 Contents Executive Summary.. 3 TaP-MS

More information

Pediatric MS treatments: What do you start with, when do you switch?

Pediatric MS treatments: What do you start with, when do you switch? Pediatric MS treatments: What do you start with, when do you switch? Tim Lotze, M.D. Associate Professor of Pediatric Neurology Texas Children s Hospital Baylor College of Medicine Disclosures Clinical

More information

Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score

Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score This section should only be completed by a neurologist or MD / ROD (Medical Doctor / Resident on Duty) involved in the

More information

Ocrevus (ocrelizumab)

Ocrevus (ocrelizumab) Ocrevus (ocrelizumab) Policy Number: 5.01.629 Last Review: 04/2018 Origination: 05/2017 Next Review: 04/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Ocrevus

More information

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 4: Myelin diseases of the CNS

CNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 4: Myelin diseases of the CNS CNS pathology Third year medical students Dr Heyam Awad 2018 Lecture 4: Myelin diseases of the CNS ILOS 1. to understand differences and similarities between diseases of myelin in CNS and PNS. 2. to understand

More information

Choices. Disease modifying treatments. Read me

Choices. Disease modifying treatments. Read me Choices Disease modifying treatments Read me Disease modifying treatments Disease modifying therapies (DMTs) are medications which modify the course of multiple sclerosis (MS) and are designed to reduce

More information

Introduction and aims of the study

Introduction and aims of the study Introduction and aims of the study 1 Chapter 1 Motor neuron diseases include the most incapacitating and life-threatening illnesses but also rather benign disorders with only mild symptoms and slow progression.

More information

Treating MS. New medicines, strong evidence, better practice? September 2015

Treating MS. New medicines, strong evidence, better practice? September 2015 Treating MS New medicines, strong evidence, better practice? September 2015 1 A Treatment Revolution for RRMS Over the past 20 years there has been a revolution in treatments for relapsing remitting MS

More information

Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100

Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100 Multiple sclerosis From Wikipedia, the free encyclopedia Demyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100 Multiple sclerosis (MS),

More information

Frequently Asked Questions For persons with multiple sclerosis

Frequently Asked Questions For persons with multiple sclerosis Patient Education Frequently Asked Questions For persons with multiple sclerosis You may have many questions about the nature of multiple sclerosis (MS) and how it may affect you or your loved one. This

More information

Circle Yes or No Y N. [If no, skip to question 8.] 2. Has the patient been compliant with therapy as verified by the prescriber?

Circle Yes or No Y N. [If no, skip to question 8.] 2. Has the patient been compliant with therapy as verified by the prescriber? 06/01/2016 Prior Authorization AETA BETTER HEALTH OF MICHIGA (MEDICAID) Tecfidera (MI88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,

More information

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY

THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY John R. Rinker, II, MD University of Alabama at Birmingham June 2, 2016 DISCLOSURES Research Support: Biogen Idec; Department of

More information

Fatigue And Beyond How Vision Captures Disease in MS

Fatigue And Beyond How Vision Captures Disease in MS Fatigue And Beyond How Vision Captures Disease in MS Salim Chahin, MD Fellow Multiple Sclerosis University of Pennsylvania Outline Introduction. Visual function testing disease outcomes. Optical Coherence

More information

Understanding your Tecfidera. treatment. Information for patients who have been prescribed treatment with Tecfidera.

Understanding your Tecfidera. treatment. Information for patients who have been prescribed treatment with Tecfidera. Understanding your Tecfidera treatment Information for patients who have been prescribed treatment with Tecfidera. Contents Treatment with Tecfidera About Multiple Sclerosis (MS) Multiple sclerosis A brief

More information

Biology 3201 Nervous System # 7: Nervous System Disorders

Biology 3201 Nervous System # 7: Nervous System Disorders Biology 3201 Nervous System # 7: Nervous System Disorders Alzheimer's Disease first identified by German physician, Alois Alzheimer, in 1906 most common neurodegenerative disease two thirds of cases of

More information

Horizon Scanning Centre July Daclizumab High Yield Process for relapsing forms of multiple sclerosis first or second line

Horizon Scanning Centre July Daclizumab High Yield Process for relapsing forms of multiple sclerosis first or second line Horizon Scanning Centre July 2014 Daclizumab High Yield Process for relapsing forms of multiple sclerosis first or second line SUMMARY NIHR HSC ID: 2635 This briefing is based on information available

More information

A Case Study: Multiple Sclerosis. Kayla Jensen February 2013

A Case Study: Multiple Sclerosis. Kayla Jensen February 2013 A Case Study: Multiple Sclerosis Kayla Jensen February 2013 Patient Profile SL is a 59 year old Caucasian Woman Lives in Utah Retired School teacher Separated from husband No Hx of tobacco/alcohol use

More information

SUBHAN ALLAH US/CANADIAN PHARMACY EXAMS EDNAN UNDERSTANDING MULTIPLE SCLEROSIS (MS) COPY RIGHT PROTECTED Page 1

SUBHAN ALLAH US/CANADIAN PHARMACY EXAMS EDNAN UNDERSTANDING MULTIPLE SCLEROSIS (MS) COPY RIGHT PROTECTED Page 1 UNDERSTANDING MULTIPLE SCLEROSIS (MS) Pathogenesis: Multiple sclerosis (MS) is the most common immune-mediated disease of the central nervous system (CNS) that specifically affects the nerves in the brain,

More information

neurological rehabilitation multiple sclerosis

neurological rehabilitation multiple sclerosis neurological rehabilitation multiple sclerosis www.cliniquevalmont.ch WHAT IS MULTIPLE SCLEROSIS? Multiple Sclerosis (MS) is an inflammatory disease which affects the central nervous system. This is characterised

More information

Epidemiology, Diagnosis, Natural History & Clinical Course

Epidemiology, Diagnosis, Natural History & Clinical Course Epidemiology, Diagnosis, Natural History & Clinical Course Multiple Sclerosis Immune-mediated, chronic, inflammatory disease precipitated by unknown environmental factors in genetically susceptible individuals

More information

Servier and GeNeuro Announce Promising post hoc Analyses of Six-Month Data from CHANGE-MS Phase 2b Study at MSParis2017

Servier and GeNeuro Announce Promising post hoc Analyses of Six-Month Data from CHANGE-MS Phase 2b Study at MSParis2017 Servier and GeNeuro Announce Promising post hoc Analyses of Six-Month Data from CHANGE-MS Phase 2b Study at MSParis2017 Anti-inflammatory effect observed in post hoc analysis in active population at 24

More information

A Glimpse at Immunomodulators in MS

A Glimpse at Immunomodulators in MS A Glimpse at Immunomodulators in MS An Interview with Mark S. Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC Multiple Sclerosis Research Unit, University of Ottowa, Ottowa Canada Ottawa Hospital Research Institute,

More information

Anticipated Launches Q Q1 2019

Anticipated Launches Q Q1 2019 Anticipated Launches Q4 2018-Q1 2019 Disease Prevalence Amyloidosis Tegsedi (inotersen) subcutaneous (SC) injection Akcea s/ionis Pharmaceuticals hereditary transthyretin amyloidosis (hattr) with polyneuropathy,

More information

EMA confirms recommendations to minimise risk of brain infection PML with Tysabri

EMA confirms recommendations to minimise risk of brain infection PML with Tysabri 25/04/2016 EMA/266665/2016 EMA confirms recommendations to minimise risk of brain infection PML with Tysabri More frequent MRI scans should be considered for patients at higher risk On 25 February 2016,

More information

MYELINATION, DEVELOPMENT AND MULTIPLE SCLEROSIS 1

MYELINATION, DEVELOPMENT AND MULTIPLE SCLEROSIS 1 MYELINATION, DEVELOPMENT AND MULTIPLE SCLEROSIS 1 Myelination, development and Multiple Sclerosis Randy Christensen Salt Lake Community College MYELINATION, DEVELOPMENT AND MULTIPLE SCLEROSIS 2 Myelination,

More information

Austin Quan Yin Newsletter The Better Health News High CRP Levels can be Deadly

Austin Quan Yin Newsletter The Better Health News High CRP Levels can be Deadly July, 2009 Volume 1, Issue 6 Special Interest Articles: Omega-3 fatty acids and diabetes Magnesium and glucose tolerance Fats and MS MS and supplementation Fish oil and lupus B vitamins and ADHD Thiamin

More information

MULTIPLE SCLEROSIS IN Managing the complexity of multiple sclerosis. Olga Ciccarelli and Alan Thompson

MULTIPLE SCLEROSIS IN Managing the complexity of multiple sclerosis. Olga Ciccarelli and Alan Thompson MULTIPLE SCLEROSIS IN 2015 Managing the complexity of multiple sclerosis Olga Ciccarelli and Alan Thompson The application of imaging biomarkers has provided new insights into the mechanisms of damage

More information

Innovation immunomodulatory treatment case study of men diagnosed with relapsing-remitting multiple sclerosis (MS)

Innovation immunomodulatory treatment case study of men diagnosed with relapsing-remitting multiple sclerosis (MS) Available online at www.worldscientificnews.com WSN 78 (2017) 249-254 EISSN 2392-2192 Innovation immunomodulatory treatment case study of men diagnosed with relapsing-remitting multiple sclerosis (MS)

More information

Do you or did you have any family members who have been diagnosed with MS? Yes No I Don t Know. Yes identical Yes not identical No

Do you or did you have any family members who have been diagnosed with MS? Yes No I Don t Know. Yes identical Yes not identical No The following survey will ask you questions about your family history of MS, your MS diagnosis and history, your symptoms, and your treatments. You may find it easier to fully answer these questions if

More information

Efficacy of interferon beta-1b as a first-line treatment in patients with Radiologically Isolated Syndrome

Efficacy of interferon beta-1b as a first-line treatment in patients with Radiologically Isolated Syndrome Efficacy of interferon beta-1b as a first-line treatment in patients with Radiologically Isolated Syndrome A CONTROLLED, RANDOMIZED, MULTICENTER, DOUBLE-BLIND CLINICAL TRIAL FINAL DEGREE PROJECT Author:

More information

Disease of Myelin. Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019

Disease of Myelin. Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019 Disease of Myelin Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019 1 I HAVE NO CONFLICTS OF INTEREST OR DISCLOSURES TO DECLARE. I HAVE NO

More information

The Role of MRI in Multiple Sclerosis

The Role of MRI in Multiple Sclerosis September 2006 The Role of MRI in Multiple Sclerosis David Cochran, Harvard Medical School Year IV Meet our patient WM 49yoF presents to Multiple Sclerosis Clinic for follow-up regarding worsening symptoms

More information

A cost-utility analysis of interferon beta for multiple sclerosis Parkin D, Miller P, McNamee P, Thomas S, Jacoby A, Bates D

A cost-utility analysis of interferon beta for multiple sclerosis Parkin D, Miller P, McNamee P, Thomas S, Jacoby A, Bates D A cost-utility analysis of interferon beta for multiple sclerosis Parkin D, Miller P, McNamee P, Thomas S, Jacoby A, Bates D Record Status This is a critical abstract of an economic evaluation that meets

More information

Medications to Slow Multiple Sclerosis Progression Multiple sclerosis disease-modifying medications

Medications to Slow Multiple Sclerosis Progression Multiple sclerosis disease-modifying medications Patient Education Medications to Slow Multiple Sclerosis Progression Multiple sclerosis disease-modifying medications There are several medications for patients with MS that help slow the course of the

More information

UNDERSTANDING MULTIPLE SCLEROSIS CINDY ANDERSON MSN, APRN, ACNP, ANP, CNRN FEBRUARY 2017

UNDERSTANDING MULTIPLE SCLEROSIS CINDY ANDERSON MSN, APRN, ACNP, ANP, CNRN FEBRUARY 2017 UNDERSTANDING MULTIPLE SCLEROSIS CINDY ANDERSON MSN, APRN, ACNP, ANP, CNRN FEBRUARY 2017 DEFINITION CHRONIC, UNPREDICTABLE, PROGRESSIVE AND DISABLING AUTOIMMUNNE DISEASE WITH SIGNIFICANT NEURODEGENERATIVE

More information

Kaspar Rufibach Methods, Collaboration, and Outreach Group (MCO) Department of Biostatistics, Roche Basel

Kaspar Rufibach Methods, Collaboration, and Outreach Group (MCO) Department of Biostatistics, Roche Basel Construction of an Estimand in a Clinical Trial on Progressive Multiple Sclerosis Kaspar Rufibach Methods, Collaboration, and Outreach Group (MCO) Department of Biostatistics, Roche Basel Acknowledgments

More information

Warm-Up. Label the parts of the neuron below.

Warm-Up. Label the parts of the neuron below. Warm-Up Label the parts of the neuron below. A B C D E F G Warm-Up 1. One neuron transmits a nerve impulse at 40 m/s. Another conducts at the rate of 1 m/s. Which neuron has a myelinated axon? 2. List

More information

Top 10 Research Findings of 2016

Top 10 Research Findings of 2016 Top 10 Research Findings of 2016 NMSS Regional Summit 2017 June 10, 2017 Rebecca Spain, MD, MSPH VA Portland Health Care System Oregon Health & Science University Disclosures Research support: NMSS Department

More information

Multiple Sclerosis and Neuroinflammation: Considering Gender differences to design therapeutic agents HALINA OFFNER

Multiple Sclerosis and Neuroinflammation: Considering Gender differences to design therapeutic agents HALINA OFFNER Multiple Sclerosis and Neuroinflammation: Considering Gender differences to design therapeutic agents HALINA OFFNER Sex differences in autoimmune disease Ratio Target Sex distribution of major autoimmune

More information

Life Long Brain Health and DMT Comparative Effectiveness

Life Long Brain Health and DMT Comparative Effectiveness Life Long Brain Health and DMT Comparative Effectiveness Timothy Vollmer, MD Professor of Neurology University of Colorado Denver Medical Director- RMMSC and Co-Director Rocky Mountain MS Center at CU

More information

Department of Defense Multiple Sclerosis Research Program

Department of Defense Multiple Sclerosis Research Program Department of Defense Multiple Sclerosis Research Program U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Programs Receipt of Funds Congressional Appropriation

More information

About MS. An Overview of Multiple Sclerosis (MS), Including Symptoms, Treatments, and Research

About MS. An Overview of Multiple Sclerosis (MS), Including Symptoms, Treatments, and Research About MS An Overview of Multiple Sclerosis (MS), Including Symptoms, Treatments, and Research About MS An Overview of Multiple Sclerosis (MS), Including Symptoms, Treatments, and Research Written by: Susan

More information

Advances in Progressive MS Research. Nicholas LaRocca, PhD

Advances in Progressive MS Research. Nicholas LaRocca, PhD Advances in Progressive MS Research Nicholas LaRocca, PhD Overview 1. What is progressive MS? 2. Key advances in progressive MS research 3. What is your Society doing to find solutions for people living

More information

IMMUNE MEDIATED NEUROMUSCULAR DISEASES FRONTIERS OF NEUROLOGY AND NEUROSCIENCE HEREDITARY NEUROMUSCULAR DISEASES P.

IMMUNE MEDIATED NEUROMUSCULAR DISEASES FRONTIERS OF NEUROLOGY AND NEUROSCIENCE HEREDITARY NEUROMUSCULAR DISEASES P. IMMUNE MEDIATED NEUROMUSCULAR DISEASES FRONTIERS OF NEUROLOGY AND NEUROSCIENCE IMMUNE MEDIATED NEUROMUSCULAR DISEASES PDF HEREDITARY NEUROMUSCULAR DISEASES P. PARIZEL AND JOHAN (PDF) PLASMA EXCHANGE AND

More information

Horizon Scanning Centre July Ocrelizumab for relapsing-remitting multiple sclerosis SUMMARY NIHR HSC ID: 3711

Horizon Scanning Centre July Ocrelizumab for relapsing-remitting multiple sclerosis SUMMARY NIHR HSC ID: 3711 Horizon Scanning Centre July 2014 Ocrelizumab for relapsing-remitting multiple sclerosis SUMMARY NIHR HSC ID: 3711 This briefing is based on information available at the time of research and a limited

More information

While MS sometimes causes severe disability, it is only rarely fatal and most people with MS have a normal life expectancy.

While MS sometimes causes severe disability, it is only rarely fatal and most people with MS have a normal life expectancy. Multiple sclerosis What is multiple sclerosis? Multiple sclerosis (MS) is a neuroinflammatory disease that affects myelin, a substance that makes up the membrane (called the myelin sheath) that wraps around

More information